Status:
NOT_YET_RECRUITING
Persistence of Oral DNA Adducts in Smokers and Vapers
Lead Sponsor:
University of Minnesota
Conditions:
Smokers
Vaping
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
This study aims to better understand what damage caused to oral cells from smoking and vaping might be important in the formation of oral cancers. We will compare levels of DNA damage between those as...
Detailed Description
DNA damage (adducts) in the oral cells will be measured in people who smoke and vape while they are using their products regularly for two weeks. Then half of the participants will be asked to stop sm...
Eligibility Criteria
Inclusion
- 21+ years old
- Good physical and mental health
- Stable physical and mental health
- Either 1) smokes cigarettes daily, 2) vapes daily, 3) does not use any tobacco or nicotine products
Exclusion
- Pregnant or nursing
- High blood pressure
- Unstable health condition(s)
- History of cancer or liver disease
Key Trial Info
Start Date :
January 31 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2030
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06983392
Start Date
January 31 2026
End Date
July 30 2030
Last Update
August 26 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.